Development of Kidney Blood Vessels

The Kidney: From Normal Development to Congenital Disease

Volumn , Issue , 2003, Pages 251-266

  Woolf, Adrian S ^a   Yuan, Hai T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344149772     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012722441-1/50019-1     Document Type: Chapter

References (110)

1. Adams R.H., Wilkinson G.A., Weiss C., Diella F., Gale N.W., Deutsch U., Risau W., Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes. Dev. 1999, 13:295-306.
2. Akeson A.L., Wetzel B., Thompson F.Y., Brooks S.K., Paradis H., Gendron R.L., Greenberg J.M. Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev. Dyn. 2000, 217:11-23.
3. Bernstein J., Cheng F., Roszka J. Glomerular differentiation in metanephric culture. Lab. Invest. 1981, 45:183-190.
4. Bi W., Drake C.J., Schwarz J.J. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 1999, 211:255-267.
5. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992, 114:521-532.
6. Brogi E., Schatteman G., Wu T., Kim E.A., Varticovski L., Keyt B., Isner J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 1996, 97:469-476.
7. Brooks P.C., Clark R.A.F., Cheresh D.A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994, 264:569-571.
8. Brown L.F., Berse B., Tognazzi K., Manseau E.J., Van de Water L., Senger D.R., Dvorak H.F., Rosen S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992, 42:1457-1461.
9. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D'Amore P.A., Shima D.T. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 1999, 5:495-502.
10. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med. 2000, 6:389-395.
11. Carey A.V., Carey R.M., Gomez R.A. Expression of α-smooth muscle actin in the developing kidney vasculature. Hypertension 1992, 19:II168-II175. (2 Suppl).
12. Colen K.L., Crisera C.A., Rose M.I., Connelly P.R., Longaker M.T., Gittes G.K. Vascular development in the mouse embryonic pancreas and lung. J. Pediatr. Surg. 1999, 34:781-785.
13. Daniel T.O., Abrahamson D. Endothelial signal integration in vascular assembly. Annu. Rev. Physiol. 2000, 62:649-671.
14. Daniel T.O., Stein E., Cerretti D.P., St.John P.L., Robert B, Abrahamson D.R. ELK and LERK-2 in developing kidney and microvascular endothelial assembly. Kidney Int. Suppl. 1996, 57:S73-S81.
15. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1170.
16. De Ruiter M.C., Poelmann R.E., Van Munsteren J.C., Mironov V., Markwald R.R., Gitternberger-de Groot A.C. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ. Res. 1997, 80:444-451.
17. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karsson S., Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 1995, 121:1845-1854.
18. Drake C.J., Cheresh D.A., Little C.D. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularisation. J. Cell Sci. 1995, 108:2655-2661.
19. Dubey R.K., Jackson E.K., Rupprecht H.D., Sterzel R.B. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cell. Curr. Opin. Nephrol. Hypertens. 1997, 6:88-105.
20. Dumont D.J., Gradwohl G., Fong G.H., Puri M.C., Gerstenstein M., Auerbach A., Breitman M.L. Dominant-negative and targeted null-mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994, 8:1897-1909.
21. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., Alitalo K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282:946-949.
22. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 1998, 140:947-959.
23. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel βHLH-PAS factor with close sequence similarity to hypoxia-inducible factor la regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA 1997, 94:4273-4278.
24. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
25. Fong G.H., Zhang L., Bryce D.M., Peng J. Increased hemangioblast commitment, not vascular disorganisation, is the primary defect in flt-1 knock out mice. Development 1999, 126:3015-3025.
26. Frid M.G., Shekhonin B.V., Koteliansky V.E., Glukhova M.A. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin. Dev. Biol. 1992, 153:185-193.
27. Gale N.W., Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999, 13:1055-1066.
28. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.-A., Rangell L., Wright B.D., Radtke F., Aguet M., Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 1999, 126:1149-1159.
29. Gory-Faure S., Prandini M.H., Pointu H., Roullot V., Pignot-Paintrand I., Vernet M., Huber P. Role of vascular endothelialcadherin in vascular morphogenesis. Development 1999, 126:2093-2102.
30. Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., Polverini P., Rosen E.M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 1993, 90:1937-1941.
31. Guignard J.P., Gouyon J.B., Adelman R.D. Arterial hypertension in the newborn infant. Biol. Neonate 1989, 55:77-83.
32. Hellstrom M., Kaln M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
33. Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 1998, 95:9349-9354.
34. Hungerford J.E., Little C.D. Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall. J. Vasc. Res. 1999, 36:2-27.
35. Hyink D.P., Tucker D.C., St.John P.L., Leardkamolkarn V., Accavitti M.A., Abrass C.K., Abrahamson D.R. Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am. J. Physiol. 1996, 270:F886-F899.
36. Irrthum A., Karkkainen A., Karkkainen M.J., Devriendt K., Alitalo K., Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 2000, 67:295-301.
37. Kaipainen A., Korhonen Pajusola K., Aprelikova O., Persico M.G., Terman B.I., Alitalo K. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 1993, 178:2077-2088.
38. Kim Y.G., Suga S.I., Kang D.H., Jefferson J.A., Mazzali M., Gordon K.L., Matsui K., Breiteneder-Geleff S., Shankland S.J., Hughes J., Kerjaschki D., Schreiner G.F., Johnson R.J. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int. 2000, 58:2390-2399.
39. Kitamoto Y., Tokunaga H., Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J. Clin. Invest. 1997, 99:2351-2357.
40. Kitamura H., Shimizu A., Masuda Y., Ishizaki M., Sugisaki Y., Yamanaka N. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model. Exp. Nephrol. 1998, 6:328-336.
41. Kloth S., Gerdes J., Wanke C., Minuth W.W. Basic fibroblast growth factor is a morphogenic modulator in kidney vessel development. Kidney Int. 1998, 53:970-978.
42. Kloth S., Suter-Crazzolara C. Modulation of renal blood vessel formation by glial cell line-derived neurotrophic factor. Microvasc Res 2000, 59:190-194.
43. Koblizek T.I, Weiss C., Yancopoulos G.D., Deutsch U., Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 1998, 8:529-532.
44. Kolatsi-Joannou M., Yuan H.T., Li X., Suda T., Woolf A.S. Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev. Dyn. 2001, 222:120-126.
45. Liu A., Dardik A., Ballermann B.J. Neutralizing TGFb1 antibody infusion in the neonatal rat delays in vivo glomerular capillary formation. Kidney Int. 1999, 56:1334-1348.
46. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 1995, 270:13333-13340.
47. Lindhahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., Soriano P., Betsholtz C. Paracrine PDGF-B/PDGF-Rβ signaling controls mesangial cell development in kidney glomeruli. Development 1998, 125:3313-3322. 1998.
48. Long D.A., Woolf A.S., Suda T., Yuan H.T. Deregulated renal angiopoietin-1 expression in folic acid-induced nephrotoxicity. Sumitted for publication. J. Am. Soc. Nephrol. 2001, 12:2721-2731.
49. Loughna S., Landels E.C., Woolf A.S. Growth factor control of developing kidney endothelial cells. Exp. Nephrol. 1996, 4:112-118.
50. Loughna S., Hardman P., Landels E., Jussila L., Alitalo K., Woolf A.S. A molecular and genetic analysis of renal glomerular capillary development. Angiogenesis 1997, 1:84-101.
51. Loughna S., Yuan H.T., Woolf A.S. Effects of oxygen on vascular patterning in Tie1/LacZ metanephric kidneys in vitro. Biochem. Biophys. Res. Commun. 1998, 247:361-366.
52. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
53. Majumdar A., Drummond I.A. Podocyte differentiation in the absence of endothelial cells as revealed in the zebrafish avascular mutant, cloche. Dev. Genet. 1999, 24:220-229.
54. Majumdar A., Lun K., Brand M., Drummond I.A. Zebrafish no isthmus reveals a role for pax2.1 in tubule differentiation and patterning events in the pronephric primordia. Development 2000, 127:2089-2098.
55. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
56. Mandriota S.J., Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 1998, 19:852-859.
57. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P.H., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846.
58. Miquerol L., Gertsenstein M., Harpal K., Rossant J., Nagy A. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 1999, 212:307-322.
59. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K.I., Eguchi H., Initsuka I., Matsui K., Imaizumi T. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000, 105:1527-1536.
60. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., Honda Y. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 1999, 274:15732-15739.
61. Oliver J.A., Al-Awqati Q. An endothelial growth factor involved in rat renal development. J. Clin. Invest. 1998, 102:1208-1219.
62. Ostendorf T., Kunter U., Eitner F., Loos A., Regele H., Kerjaschki D., Henninger D.D., Janjic N., Floege J. VEGF165 mediates glomerular endothelial repair. J. Clin. Invest. 1999, 104:913-923.
63. Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilisation, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 1999, 79:213-223.
64. Pardanaud L., Luton D., Prigent M., Bourcheix L.M., Catala M., Dieterlen-Lievre F. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 1996, 122:1363-1371.
65. Park F., Mattson D.L., Roberts L.A., Cowley A.W. Evidence for the presence of smooth muscle alpha-actin within pericytes of the renal medulla. Am. J. Physiol. 1997, 273:R1742-R1748.
66. Partanen J., Puri M.C., Schwartz L., Fischer K.D., Bernstein A., Rossant J. Cell autonomous functions of the receptor tyrosine kinase TIE in late phases of angiogenic capillary growth and endothelial cell survival during murine development. Development 1996, 122:3013-3021.
67. Pereira F.A., Qiu Y., Zhou G., Tsai M.J., Tsai S.Y. The orphan nuclear receptor COUP-TF11 is required for angiogenesis and heart development. Genes Dev. 1999, 13:1037-1049.
68. Pillebout E., Burtin M., Yuan H.T., Briand P., Woolf A.S., Friedlander G., Terzi F. Proliferation and remodeling of the peritubular microcirculation after nephron reduction: Association with the progression of renal lesions. Am. J. Pathol. 2001, 159:547-560.
69. Procopio W.N., Pelavin P.I., Lee W.M., Yeilding N.M. Angiopoietin-1 and -2 coiled coil domains mediate distinct homooligomerisation patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 1999, 274:30196-30201.
70. Puri M.C., Partanen J., Rossant J., Bernstein A. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 1999, 126:4569-4580.
71. Raleigh J.A., Dewhirst M.W., Thrall D.E. Measuring tumor hypoxia. Semin. Radiat. Oncol. 1996, 6:37-45.
72. Reddi V., Zaglul A., Pentz E.S., Gomez R.A. Renin-expressing cells are associated with branching of the developing kidney vasculature. J. Am. Soc. Nephrol. 1998, 9:63-71.
73. Risdon R.A., Woolf A.S. Development of the kidney. Heptinstall's Pathology of the Kidney 1998, 67-84. Lippincott-Raven, Cambridge. 5th ed. J.C. Jennette, J.L. Olson, M.M. Schwartz, F.6. Silva (Eds.).
74. Robert B., St.John P.L., Abrahamson D.R. Direct visualisation of renal vascular morphogenesis in Flk1 heterozygous mutant mice. Am. J. Physiol. 1998, 275:F164-F172.
75. Robert B., Zhao X., Abrahamson D.R. Coexpression of neuropilin-1, Flk1 and VEGF(164) in developing and mature mouse kidney glomeruli. Am. J. Physiol. Renal Physiol. 2000, 279:F275-F282.
76. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell. Sci. 1995, 108:2369-2379.
77. Sariola H., Ekblom P., Lehtonen E., Saxen L. Differentiation and vascularization of the metanephric kidney grafted on the chorioallantoic membrane. Dev. Biol. 1983, 96:427-435.
78. Sariola H., Timpl R., von der Mark K., Mayne R., Fitch J.M., Lisenmayer T.F., Ekblom P. Dual origin of glomerular basement membrane. Dev. Biol. 1984, 101:86-96.
79. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles for the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
80. Shalaby F., Rossant J., Yamaguchi T.P., Gerstenstein M., Wu X.-F., Breitman M.L., Schuh A.C. Failure of blood island formation and vasculogenesis in flk-1 deficient mice. Nature 1995, 376:62-66.
81. Simon M., Grone H.-J., Johren O., Kullmer J., Plate H.K., Risau W., Fuchs E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 1995, 268:F240-F250.
82. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neurophilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735-745.
83. Soriano P. Abnormal kidney development and hematological disorders in platelet derived growth factor β-receptor mutant mice. Genes Dev. 1994, 8:1888-1896.
84. Stainier D.Y., Weinstein B.M., Detrich H.W., Zou L.I., Fishman M.C. Cloche, an early acting zebrafish gene, is required by both the endothelial and hemopoietic lineages. Development 1995, 121:3141-3150.
85. Stratmann A., Risau W., Plate K.H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 1998, 153:1459-1466.
86. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
87. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., Sato T.N., Yancopoulos G.D. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
88. Takakura N., Huang X.L., Naruse T., Hamguchi I., Dumont D.J., Yancopoulos G.D., Suda T. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 1998, 9:677-686.
89. Tanaka S., Mori M., Sakamoto Y., Makuuchi M., Sugimachi K., Wands J.R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J. Clin. Invest. 1999, 103:341-345.
90. Tian H., McKnight S.L, Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1999, 11:72-82.
91. Tisher C.C., Madsen K.M. Anatomy of the kidney. The Kidney 1996, 3-71. Saunders, Philadelphia. 5th ed. B.M. Brenner (Ed.).
92. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
93. Thurston G., Rudge J.S.M., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Med. 2000, 6:460-463.
94. Towers P.R., Woolf A.S., Hardman P. Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp. Nephrol. 1998, 6:337-351.
95. Tuder R.M., Flook B.E., Voelkel N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or chronic hypoxia: Modulation of gene expression by nitric oxide. J. Clin. Invest. 1995, 95:1798-1807.
96. Tufro A., Norwood V.F., Carey R.M., Gomex R.A. Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J. Am. Soc. Nephrol. 1999, 10:2125-2134.
97. Tufro-McReddie A., Norwood V.F., Carey R.M., Gomez R.A. Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev. Biol. 1997, 183:139-149.
98. Tufro-McReddie A., Romano L.M., Harris J.M., Ferder L., Gomez R.A. Angiotensin II regulates nephrogenesis and renal vascular development. Am. J. Physiol. 1995, 269:F110-F115.
99. Valenzuela D.M., Griffiths J.A., Rojas J., Aldrich T.H., Jones P.F., Zhou H., McClain J., Copeland N.G., Gilbert D.J., Jenkins N.A., Huang T., Papadopoulos N., Maisonpierre P.C., Davis S., Yancopoulos G.D. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 1999, 96:1904-1909.
100. Vikkula M., Boon L.M., Carraway K.L., Calvert J.T., Diamonti A.J., Goumnerov B., Pasyk K.A., Marchuk D.A., Warman M.L., Cantley L.C., Mulliken J.B., Olsen B.R. Vascular dysmorphogenesis caused by activating mutation in the receptor tyrsoine kinase TIE2. Cell 1996, 87:1181-1190.
101. Woolf A.S. Embryology of the kidney. Pediatric Nephrology 1999, 1-19. Williams and Wilkins, Philadelphia. 4th Ed. T.M. Barratt, A. Avner, W. Harmon (Eds.).
102. Woolf A.S., Cale C.M. Roles of growth factors in renal development. Curr. Opin. Nephrol. Hypertens. 1997, 6:10-14.
103. Woolf A.S., Kolatsi-Joannou M., Hardman P., Andermarcher E., Moorby C., Fine L.G., Jat P.S., Noble M.D., Gherardi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell. Biol. 1995, 128:171-184.
104. Woolf A.S., Loughna S. Origin of glomerular capillaries: Is the verdict in?. Exp. Nephrol. 1998, 6:17-21.
105. Woolf A.S., Palmer S.J., Snow M.L., Fine L.G. Creation of a functioning chimeric mammalian kidney. Kidney Int. 1990, 38:991-997.
106. Yuan H.T., Suri C., Landon D.N., Yancopoulos G.D., Woolf A.S. Angiopoietin-2 is a site specific factor in differentiation of mouse renal vasculature. J. Am. Soc. Nephrol. 2000, 11:1055-1066.
107. Yuan H.T., Yang S.P., Woolf A.S. Hypoxia upregulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int. 2000, 58:1912-1919.
108. Yuan H.T., Suri C., Yancopoulos G.D., Woolf A.S. Expression of angiopoietin-1, angiopoietin-2 and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J. Am. Soc. Nephrol. 1999, 10:1722-1736.
109. Yuan H.T., Suri C., Yancopoulos G.D., Woolf A.S. Tie2 and its angiopoietin-1 ligand in normal nephrogenesis and Wilms' tumors. J. Am. Soc. Nephrol. 1999, 10:413A. [Abstract].
110. Yuan H.T., Tipping P.G., Li X.Z., Long D.A., Woolf A.S. Angiopoietin correlates with glomerular capillary loss in antiglomerular basement membrane glomerulonephritis. Kidney Int. 2002, 61:2078-2089.